UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature (London), ISSN 0028-0836, 07/2017, Volume 547, Issue 7662, pp. 222 - 226
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immunotherapy - methods | Neoplasm Recurrence, Local - prevention & control | Antibodies, Monoclonal - pharmacology | Humans | Vaccination | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Epitopes - genetics | Mutation - genetics | B7-H1 Antigen - immunology | CD8 Antigens - immunology | RNA - genetics | beta 2-Microglobulin - deficiency | Cancer Vaccines - genetics | Epitopes - immunology | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Neoplasm Metastasis | Melanoma - genetics | Melanoma - immunology | T-Lymphocytes - immunology | Melanoma - therapy | Precision Medicine - methods | Prevention | Genetic aspects | RNA | Health aspects | Mutation (Biology) | Cancer | Antigens | PD-1 protein | Genomics | Melanoma | Lymphocytes T | T cell receptors | Vaccines | Metastasis | Epitopes | Ribonucleic acid--RNA | Patients | Immunity | Metastases | Lymphocytes | Immunotherapy | Infiltration | Mutation | Tumors | Index Medicus
Journal Article
Expert review of vaccines, ISSN 1476-0584, 02/2012, Volume 11, Issue 2, pp. 189 - 209
cytokine | vaccine | adjuvant | DNA | immunization | plasmid | electroporation | Life Sciences & Biomedicine | Immunology | Science & Technology | Vaccines, DNA - genetics | Immunization | Adjuvants, Immunologic - administration & dosage | Guinea Pigs | Cancer Vaccines - administration & dosage | Humans | Vaccines, DNA - immunology | Cancer Vaccines - adverse effects | Treatment Outcome | Clinical Trials as Topic | Electroporation - methods | Vaccines, DNA - administration & dosage | Adjuvants, Immunologic - adverse effects | Cancer Vaccines - genetics | Cancer Vaccines - immunology | Neoplasms - therapy | Animals | Neoplasms - immunology | Plasmids | Vaccines, DNA - adverse effects | Communicable Diseases - immunology | Mice | Cytokines - genetics | Cytokines - immunology | Medical research | Research | Vaccines | Contamination | Cancer vaccines | Anopheles | Codon | Genetic research | Medicine, Experimental | Genetic aspects | Gene therapy | Health aspects | Tumors | Cancer | Infectious diseases | Reviews | Immunogenicity | Therapeutic applications | Adjuvants | Electroporation | DNA vaccines | Models | Codons | Promoters | Index Medicus
Journal Article
Infection, genetics and evolution, ISSN 1567-1348, 10/2017, Volume 54, pp. 402 - 416
Human papillomavirus (HPV) vaccine | Vaccine design | Minor capsid protein (L2) | Cervical cancer (CxCa) | Immunoinformatics | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Papillomavirus Vaccines - genetics | Vaccines, Subunit - genetics | Humans | Epitopes, T-Lymphocyte - genetics | Epitopes, B-Lymphocyte - immunology | Papillomaviridae - genetics | Papillomaviridae - immunology | Epitopes, B-Lymphocyte - genetics | Flagellin - genetics | Malaria Vaccines - immunology | Capsid Proteins - immunology | Adjuvants, Immunologic - genetics | Oncogene Proteins, Viral - genetics | Epitopes, T-Lymphocyte - immunology | Computational Biology - methods | Flagellin - immunology | Vaccines, Subunit - chemistry | Vaccines, Subunit - immunology | Molecular Dynamics Simulation | Animals | Papillomavirus Vaccines - chemistry | Papillomavirus Infections - prevention & control | Papillomavirus Vaccines - immunology | Molecular Docking Simulation | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Malaria Vaccines - genetics | Prevention | Peptides | Viral proteins | Analysis | Molecular dynamics | Vaccines | T cells | Health aspects | Papillomavirus infections | Cervical cancer | Antigenic determinants | Cancer | Index Medicus
Journal Article
Archives of virology, ISSN 0304-8608, 3/2018, Volume 163, Issue 3, pp. 587 - 597
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | Life Sciences & Biomedicine | Science & Technology | Vaccines, DNA - genetics | Adjuvants, Immunologic - administration & dosage | Papillomavirus Vaccines - genetics | Epithelial Cells - drug effects | Tumor Necrosis Factor-alpha - genetics | Vaccination | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Vaccines, DNA - administration & dosage | Melatonin - administration & dosage | Papillomavirus E7 Proteins - genetics | Cancer Vaccines - genetics | T-Lymphocytes, Cytotoxic - drug effects | Tumor Necrosis Factor-alpha - immunology | Melatonin - immunology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Interferon-gamma - genetics | Interleukin-4 - genetics | Papillomavirus Vaccines - administration & dosage | T-Lymphocytes, Cytotoxic - immunology | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Plasmids - immunology | Gene Expression Regulation | Vascular Endothelial Growth Factor A - immunology | Papillomavirus Infections - mortality | Tumor Burden | Cancer Vaccines - immunology | Interleukin-4 - immunology | Animals | Lymphocyte Activation - drug effects | Papillomavirus Infections - prevention & control | Epithelial Cells - immunology | Interferon-gamma - immunology | Plasmids - chemistry | Survival Analysis | Cell Line, Tumor | Papillomavirus Vaccines - immunology | Cell Proliferation - drug effects | Mice | Human papillomavirus 16 - genetics | Plasmids - administration & dosage | Melatonin | Endothelial growth factors | Analysis | DNA | Resveratrol | Genetic research | Vaccines | T cells | Health aspects | Papillomavirus infections | Cell proliferation | Cell survival | CD8 antigen | Cytotoxicity | Lymphocytes T | DNA vaccines | Tumor necrosis factor-α | Cancer vaccines | Human papillomavirus | Interleukin 4 | γ-Interferon | Combined vaccines | Interleukin 10 | Antitumor activity | Interferon | Lactic acid | Vascular endothelial growth factor | Enzyme-linked immunosorbent assay | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article